Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

´©µå¸¶¿ì½º¿¡ ÀÌÁ¾ÀÌ½ÄµÈ ±¸°­ÆíÆò»óÇǼ¼Æ÷¾ÏÁ¾¿¡ ´ëÇÑ thalidomideÀÇ Ç×¾ÏÈ¿°ú¿Í Ç÷°üÇü¼º¾ïÁ¦¿¡ °üÇÑ ¿¬±¸

ANTI-TUMOR AND ANTI-ANGIOGENIC EFFECT OF THALIDOMIDE ON ORAL SQUAMOUS CELL CARCINOMA XENOGRAFTS IN NUDE MICE

´ëÇѱ¸°­¾Ç¾È¸éº´¸®ÇÐȸÁö 2003³â 27±Ç 4È£ p.330 ~ 336
±è¼ö°ï, ¸íÈÆ, ÇÔÁø¼÷,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¼ö°ï (  ) - ¼­¿ï´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­¾Ç¾È¸é¿Ü°úÇб³½Ç
¸íÈÆ (  ) - ¼­¿ï´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­¾Ç¾È¸é¿Ü°úÇб³½Ç
ÇÔÁø¼÷ (  ) - ¼­¿ï´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­¾Ç¾È¸é¿Ü°úÇб³½Ç

Abstract

[ÃʷϾøÀ½:No abstract]

Å°¿öµå

Antiangiogenesis;Thalidomide;Oral squamous cell carcinoma;CD31;VEGF

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI